In the guidance published on the 22nd March 2019, PHE confirmed, based on JCVI advice the range of recommended flu vaccines in 2019/20 has been extended and include those outlined below:

• Live attenuated influenza vaccine (LAIV) - For children aged 2 to 17 years
• Egg grown quadrivalent influenza vaccine (QIVe) - For those aged 16 - 64 years
• Cell-based quadrivalent influenza vaccine (QIVc) - For those aged 16 - 64 years and those aged 65 years and over
• Adjuvanted trivalent influenza vaccine (aTIV) - For those aged 65 years and over

You can view a copy of this guidance by clicking here.

As recommended by the World Health Organisation^a the composition of the vaccines for the northern hemisphere contain the following:

• an A/Brisbane/02/2018 (H1N1)pdm09-like virus;
• an A/Kansas/14/2017 (H3N2)-like virus;
• a B/Colorado/06/2017-like virus (B/Victoria/2/87 lineage); and
• For the quadrivalent - a B/Phuket/3073/2013-like virus (B/Yamagata/16/88 lineage).

a https://www.who.int/influenza/vaccines/virus/recommendations/2019_20_north/en/